ATE52510T1 - Benzo(c>-1,5-naphthyridine, ein verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel. - Google Patents

Benzo(c>-1,5-naphthyridine, ein verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.

Info

Publication number: ATE52510T1
Authority: AT; Austria
Prior art keywords: loweralkyl; naphthyridine; benzo; production; intermediate products
Prior art date: 1985-03-13

Application number

AT86103085T

Other languages

English (en)

Inventor

Lawrence L Martin

Linda L Setescak

Susan J Scott

Original Assignee

Hoechst Roussel Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-13

Filing date

1986-03-07

Publication date

1990-05-15

1986-03-07 Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma

1990-05-15 Application granted granted Critical

1990-05-15 Publication of ATE52510T1 publication Critical patent/ATE52510T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Display Devices Of Pinball Game Machines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)

AT86103085T 1985-03-13 1986-03-07 Benzo(c>-1,5-naphthyridine, ein verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel. ATE52510T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/711,327 US4652567A (en)	1985-03-13	1985-03-13	Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement
EP86103085A EP0197318B1 (de)	1985-03-13	1986-03-07	Benzo[c]-1,5-naphthyridine, ein Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number	Publication Date
ATE52510T1 true ATE52510T1 (de)	1990-05-15

Family

ID=24857642

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86103085T ATE52510T1 (de)	1985-03-13	1986-03-07	Benzo(c>-1,5-naphthyridine, ein verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.

Country Status (19)

Country	Link
US (1)	US4652567A (de)
EP (1)	EP0197318B1 (de)
JP (1)	JPS61212585A (de)
KR (1)	KR860007255A (de)
AT (1)	ATE52510T1 (de)
AU (1)	AU590748B2 (de)
CA (1)	CA1248108A (de)
DE (1)	DE3671017D1 (de)
DK (1)	DK114386A (de)
ES (4)	ES8707528A1 (de)
FI (1)	FI861001A (de)
GR (1)	GR860681B (de)
HU (2)	HU197007B (de)
IL (1)	IL78117A0 (de)
NO (1)	NO163489B (de)
NZ (1)	NZ215439A (de)
PH (1)	PH22279A (de)
PT (1)	PT82187B (de)
ZA (1)	ZA861837B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4766217A (en) *	1984-01-13	1988-08-23	Boehringer Ingelheim Kg	Preparation of 5,6-dihydro-pyrrolo[2,1-a]isoquinolines
US5202440A (en) *	1987-10-05	1993-04-13	Pfizer Inc.	Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
WO1989002739A1 (en) *	1987-10-05	1989-04-06	Pfizer Inc.	4-aminopyridine derivatives
US5994367A (en)	1997-03-07	1999-11-30	The University Of North Carolina At Chapel Hill	Method for treating tumors using 2-aryl-naphthyridin-4-ones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2273533A1 (fr) *	1974-06-04	1976-01-02	Ferlux Sa	Nouveaux derives n-substitues d'acides pyrrolidones-2 carboxyliques-5
US4297358A (en) *	1979-01-16	1981-10-27	Ciba-Geigy Corporation	Novel 4,7-phenanthroline derivatives and pharmaceutical compositions containing them and their use
BE880455A (fr) *	1979-01-22	1980-06-06	Sandoz Sa	Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine

1985
- 1985-03-13 US US06/711,327 patent/US4652567A/en not_active Expired - Lifetime
1986
- 1986-03-07 DE DE8686103085T patent/DE3671017D1/de not_active Expired - Fee Related
- 1986-03-07 AT AT86103085T patent/ATE52510T1/de not_active IP Right Cessation
- 1986-03-07 EP EP86103085A patent/EP0197318B1/de not_active Expired - Lifetime
- 1986-03-11 IL IL78117A patent/IL78117A0/xx unknown
- 1986-03-11 PH PH33508A patent/PH22279A/en unknown
- 1986-03-11 NZ NZ215439A patent/NZ215439A/xx unknown
- 1986-03-11 CA CA000503758A patent/CA1248108A/en not_active Expired
- 1986-03-11 HU HU861028A patent/HU197007B/hu not_active IP Right Cessation
- 1986-03-11 FI FI861001A patent/FI861001A/fi not_active Application Discontinuation
- 1986-03-11 HU HU885579A patent/HU201756B/hu not_active IP Right Cessation
- 1986-03-11 ES ES552874A patent/ES8707528A1/es not_active Expired
- 1986-03-12 ZA ZA861837A patent/ZA861837B/xx unknown
- 1986-03-12 DK DK114386A patent/DK114386A/da not_active Application Discontinuation
- 1986-03-12 AU AU54658/86A patent/AU590748B2/en not_active Ceased
- 1986-03-12 GR GR860681A patent/GR860681B/el unknown
- 1986-03-12 NO NO860933A patent/NO163489B/no unknown
- 1986-03-12 JP JP61052750A patent/JPS61212585A/ja active Pending
- 1986-03-13 PT PT82187A patent/PT82187B/pt unknown
- 1986-03-13 KR KR1019860001804A patent/KR860007255A/ko not_active Application Discontinuation
- 1986-11-17 ES ES557208A patent/ES8800941A1/es not_active Expired
- 1986-11-17 ES ES557207A patent/ES8801269A1/es not_active Expired
1987
- 1987-10-15 ES ES557768A patent/ES8801270A1/es not_active Expired

Also Published As

Publication number	Publication date
AU5465886A (en)	1986-09-18
DK114386D0 (da)	1986-03-12
DK114386A (da)	1986-09-14
EP0197318A1 (de)	1986-10-15
JPS61212585A (ja)	1986-09-20
PH22279A (en)	1988-07-14
AU590748B2 (en)	1989-11-16
EP0197318B1 (de)	1990-05-09
CA1248108A (en)	1989-01-03
FI861001A (fi)	1986-09-14
PT82187A (en)	1986-04-01
NO860933L (no)	1986-09-15
ES557208A0 (es)	1987-12-01
NO163489B (no)	1990-02-26
ES8707528A1 (es)	1987-08-01
FI861001A0 (fi)	1986-03-11
US4652567A (en)	1987-03-24
ES8801269A1 (es)	1988-01-01
HU201756B (en)	1990-12-28
ES552874A0 (es)	1987-08-01
ES557768A0 (es)	1988-01-01
ZA861837B (en)	1987-06-24
DE3671017D1 (de)	1990-06-13
ES557207A0 (es)	1988-01-01
HUT40658A (en)	1987-01-28
HU197007B (en)	1989-02-28
NZ215439A (en)	1990-03-27
ES8800941A1 (es)	1987-12-01
ES8801270A1 (es)	1988-01-01
PT82187B (en)	1988-01-07
GR860681B (en)	1986-07-14
KR860007255A (ko)	1986-10-10
IL78117A0 (en)	1986-07-31

Similar Documents

Publication	Publication Date	Title
ATE38661T1 (de)	1988-12-15	Zwischenprodukt und verfahren zu dessen herstellung.
DE3772905D1 (de)	1991-10-17	Alpha-alkyl-4-amino-3-chinolin-methanole und 1-(4-aralkylamino-3-chinolyl)alkanone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69025941D1 (de)	1996-04-18	Dem Physostigmin verwandte 4- und 6-Carbamate, ein Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE127807T1 (de)	1995-09-15	N-heteroaryl-purin-6-amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE143020T1 (de)	1996-10-15	Aminocarbonylcarbamate verwandt mit physostigmin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE47856T1 (de)	1989-11-15	11-substituierte 5h,11h-pyrrolo(2,1c>(1,4>benzoxazepine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE140006T1 (de)	1996-07-15	1-(pyrido(3,4-b>-1,4-oxazinyl-4-yl)-1h-indole, zwischenprodukte und ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE201024T1 (de)	2001-05-15	Carbamatderivate von 4-amino-3-isoxazolidinonen und 3-amino-1-hydroxypyrrolidinon-2-onen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3780015D1 (de)	1992-07-30	Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE52510T1 (de)	1990-05-15	Benzo(c>-1,5-naphthyridine, ein verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE111899T1 (de)	1994-10-15	1,2,3,4-tetrahydro-1,9-acridindiamine, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE68902386D1 (de)	1992-09-10	N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
ATE171942T1 (de)	1998-10-15	1-piperazinyl-2-butene und 2-butyne, zwischenverbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE56713T1 (de)	1990-10-15	1,2,3,4,4a,9b-hexahydro-4aaminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE151422T1 (de)	1997-04-15	8-azabicyclo(3.2.1>octylalkylthiazolidinone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE40118T1 (de)	1989-02-15	Benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel.
ATE92074T1 (de)	1993-08-15	Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3483011D1 (de)	1990-09-27	Substituierte alkylamino-derivate von 6,11-dihydro-11-oxo-dibenz(b,e)-oxepin, verfahren zu ihrer herstellung, ihre zwischenprodukte und ihre verwendung als arzneimittel.
DE3851697D1 (de)	1994-11-03	2-Amino-1,2,3,4-tetrahydroisochinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.

Legal Events

Date	Code	Title	Description
1990-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties